Cabaletta Bio (CABA) Retained Earnings (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Retained Earnings of -$517.0 million for Q4 2025, down 48.08% year-over-year from -$995.7 million in Q4 2024, and down 2247739.13% quarter-over-quarter from $23000.0 in Q3 2025.
Cabaletta Bio (CABA) Retained Earnings (2018 - 2026) Analysis & Trends
Cabaletta Bio's Retained Earnings history runs 8 years deep, the most recent figure standing at -$517.0 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 48.08% year-over-year to -$517.0 million; the TTM figure through Dec 2025 stood at -$517.0 million (down 48.08% YoY), while the FY2025 annual figure was -$517.0 million, down 48.08% from the prior year.
- Retained Earnings for Q4 2025 stood at -$517.0 million, down from $23000.0 in the prior quarter.
- The five-year high for Retained Earnings was $39000.0 in Q4 2023, with the low at -$517.0 million in Q4 2025.
- The 5-year median for Retained Earnings is -$92.9 million (2021), against an average of -$126.0 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 4184533.33% in 2022, then surged 182.98% in 2023.
- Cabaletta Bio's Retained Earnings stood at -$112.6 million in 2021, then soared by 99.96% to -$47000.0 in 2022, then soared by 182.98% to $39000.0 in 2023, then tumbled by 895230.77% to -$349.1 million in 2024, then plunged by 48.08% to -$517.0 million in 2025.
- Business Quant data shows CABA's Retained Earnings at -$517.0 million in Q4 2025, $23000.0 in Q3 2025, and $1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | -611.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -611.49 Mn |
| Dec 31, 2025 | -516.96 Mn |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | -385.04 Mn |
| Dec 31, 2024 | -349.10 Mn |
| Sep 30, 2024 | -316.52 Mn |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | -195.90 Mn |
| Mar 31, 2023 | -181.42 Mn |
| Dec 31, 2022 | -47,000.00 |
| Sep 30, 2022 | -149.87 Mn |
| Jun 30, 2022 | -249,000.00 |
| Mar 31, 2022 | -125.53 Mn |
| Dec 31, 2021 | -112.59 Mn |
| Sep 30, 2021 | -98.70 Mn |
| Jun 30, 2021 | -87.14 Mn |